Clinical Study

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study To Assess The Efficacy And Safety Of Oral Bps-314D-Mr Added-On To Treprosti

Posted Date: May 15, 2019

  • Investigator: Jean Elwing
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to compare the effect of an oral (by mouth) prostanoid to placebo, when both are used with inhaled Tyvaso. The study will also evaluate the safety of this prostanoid. This study will also keep track of changes in your exercise ability to determine if your PAH worsens.

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Have Pulmonary Arterial Hyperten

Keywords:

Lung Disease, Pah, Pulmonary, Pulmonary Arterial H, Shortness Of Breath

For More Information:

Melissa Banuelos
(513) 558-2187
banuelma@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.